Press release
Investigation announced for Investors in shares of Talis Biomedical Corporation (NASDAQ: TLIS) over possible Violations of Securities Laws
An investigation for investors in Talis Biomedical Corporation (NASDAQ: TLIS) shares over potential securities laws violations.
Investors who purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Talis Biomedical Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Redwood City, CA based Talis Biomedical Corporation operates as a molecular diagnostic company.
On or about February 12, 2021, Talis Biomedical Corporation sold approximately 13.8 million shares of stock in its initial public stock offering (the "IPO") at $16 a share, raising nearly $221 million in new capital.
On August 10, 2021, Talis Biomedical Corporation reported its 2nd quarter financial results. During the earnings call, it was disclosed that "In the near term, our development time lines have been extended by delays in the launching of our COVID-19 test and manufacturing scale."
Then, on August 30, 2021, Talis announced that its President, CEO, and Director resigned.
Those who purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Talis Biomedical Corporation (NASDAQ: TLIS) over possible Violations of Securities Laws here
News-ID: 3457811 • Views: …
More Releases from Shareholders Foundation, Inc.
Lawsuit Alert: Investors who lost money with shares of Molina Healthcare, Inc. ( …
An investor, who purchased shares of Molina Healthcare, Inc. (NYSE: MOH), filed a lawsuit over alleged violations of Federal Securities Laws by Molina Healthcare, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Molina Healthcare, Inc. (NYSE: MOH) have certain options and for certain investors are short and strict deadlines running. Deadline: December 02, 2025. NYSE: MOH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
CTO Realty Growth, Inc. (NYSE: CTO) Long Term Investor Alert: Investigation of p …
An investigation on behalf of current long-term investors in shares of CTO Realty Growth, Inc. (NYSE: CTO) concerning potential breaches of fiduciary duties by certain directors and officers of CTO Realty Growth, Inc. was announced.
Investors who are current long term investors in CTO Realty Growth, Inc. (NYSE: CTO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a…
Lawsuit filed for Investors who lost money with shares of Marex Group plc (NASDA …
An investor, who purchased shares of Marex Group plc (NASDAQ: MRX), filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Marex Group plc in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, have certain options…
LifeMD, Inc. (NASDAQ: LFMD) Investor Alert: Deadline in Lawsuit on October 27, 2 …
A deadline is coming up on October 27, 2025 in the lawsuit filed for certain investors of LifeMD, Inc. (NASDAQ: LFMD) over alleged securities laws violations by LifeMD, Inc.
Investors who purchased shares of LifeMD, Inc. (NASDAQ: LFMD) have certain options and there are strict and short deadlines running. Deadline: October 27, 2025. LifeMD, Inc. (NASDAQ: LFMD) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Talis
Optimal Reptile Care with Talis-us: Premium Products for Health and Comfort
Talis-us specializes in a wide array of products tailored for reptiles, emphasizing their health and comfort. From essential lighting mimicking natural sunlight to heating solutions ensuring proper temperature gradients, Talis-us offers diverse food options. With a commitment to quality and customer education, Talis-us supports reptile owners in providing optimal care.
Image: https://www.getnews.info/uploads/bdb2abd5aa8fd356b5fa2dcfb4aa4163.png
Talis-us offers a large selection of items that are made to specifically address the needs of reptiles [https://talis-us.com/blogs/news/talis-us-reptile-supply-quality-products-for-your-reptile-needs]. The…
Gate Shut-Off Valve Market ; Eminent Players - Schneider Electric, Johnson Contr …
In the past few years, the Gate Shut-Off Valve market experienced a huge change under the influence of COVID-19 and Russia-Ukraine War, the global market size of Gate Shut-Off Valve reached the predicted milestone in 2022 with the rising CAGR from 2017-2022. Facing the complicated international situation, the future of the Gate Shut-Off Valve market is full of uncertain. Report predicts that the global Gate Shut-Off Valve market size will…
Investigation announced for Long-Term Investors in shares of Talis Biomedical Co …
An investigation was announced over possible breaches of fiduciary duties by certain directors of Talis Biomedical Corporation.
Investors who are current long term investors in Talis Biomedical Corporation (NASDAQ: TLIS) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: TLIS stocks follows a lawsuit filed against Talis Biomedical Corporation…
Deadline on March 8th in Lawsuit for Investors in Talis Biomedical Corporation ( …
The Shareholders Foundation announced that a deadline is coming up on March 8, 2021 in the lawsuit filed for certain investors of Talis Biomedical Corporation (NASDAQ: TLIS).
Investors who purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS) have certain options and there are strict and short deadlines running. Deadline: March 8, 2021. Talis Biomedical Corporation (NASDAQ: TLIS) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According…
Lawsuit filed for Investors in shares of Talis Biomedical Corporation (NASDAQ: T …
An investor, who purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS), filed a lawsuit over alleged Securities Laws violations by Talis Biomedical Corporation in connection with the Company’s February 2021 initial public offering (“IPO”).
Investors who purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS) have certain options and for certain investors are short and strict deadlines running. Deadline: March 8, 2021. NASDAQ: TLIS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Investigation announced for Investors in shares of Talis Biomedical Corporation …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Talis Biomedical Corporation.
Investors who purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Talis Biomedical directors breached their fiduciary duties and caused damage to the company and its shareholders.
Menlo Park,…
